{"id":980,"date":"2022-02-22T19:50:06","date_gmt":"2022-02-22T19:50:06","guid":{"rendered":"https:\/\/glossaire.myeloma.ca\/?glossaire=beta-2-microglobulin-%CE%B22m"},"modified":"2022-02-22T19:50:06","modified_gmt":"2022-02-22T19:50:06","slug":"beta-2-microglobulin-%ce%b22m","status":"publish","type":"glossary","link":"https:\/\/myeloma.ca\/fr\/glossaire\/beta-2-microglobulin-%ce%b22m\/","title":{"rendered":"B\u00eata-2 microglobuline:"},"content":{"rendered":"<p>Petite prot\u00e9ine pr\u00e9sente dans le sang. Des niveaux \u00e9lev\u00e9s apparaissent chez les patients atteints d\u2019un my\u00e9lome actif. Des niveaux bas ou normaux apparaissent chez les patients atteints d\u2019un my\u00e9lome pr\u00e9coce ou peu actif. Environ 10% des patients pr\u00e9sentant un my\u00e9lome ne produisant pas de b2M. En p\u00e9riode de rechute, la b2M peut augmenter avant la variation du niveau de la prot\u00e9ine du my\u00e9lome. Par cons\u00e9quent, dans 90% des cas, la b2M est tr\u00e8s utile pour d\u00e9terminer l\u2019activit\u00e9 de la maladie.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Petite prot\u00e9ine pr\u00e9sente dans le sang. Des niveaux \u00e9lev\u00e9s apparaissent chez les patients atteints d\u2019un my\u00e9lome actif. Des niveaux bas ou normaux apparaissent chez les patients atteints d\u2019un my\u00e9lome pr\u00e9coce ou peu actif. Environ 10% des patients pr\u00e9sentant un my\u00e9lome ne produisant pas de b2M. En p\u00e9riode de rechute, la b2M peut augmenter avant la [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"template":"","glossary-cat":[],"class_list":["post-980","glossary","type-glossary","status-publish","hentry"],"acf":[],"aioseo_notices":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary\/980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary\/980\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=980"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/glossary-cat?post=980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}